Laffer Tengler Investments Inc. Increases Position in Intuitive Surgical, Inc. $ISRG

Laffer Tengler Investments Inc. increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 80.0% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,125 shares of the medical equipment provider’s stock after acquiring an additional 500 shares during the quarter. Laffer Tengler Investments Inc.’s holdings in Intuitive Surgical were worth $611,000 as of its most recent filing with the SEC.

Other hedge funds have also recently bought and sold shares of the company. Aaron Wealth Advisors LLC increased its stake in shares of Intuitive Surgical by 0.8% in the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after buying an additional 19 shares during the last quarter. J. W. Coons Advisors LLC raised its stake in Intuitive Surgical by 1.4% during the first quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock valued at $741,000 after buying an additional 20 shares in the last quarter. Exencial Wealth Advisors LLC raised its stake in Intuitive Surgical by 3.1% during the first quarter. Exencial Wealth Advisors LLC now owns 661 shares of the medical equipment provider’s stock valued at $327,000 after buying an additional 20 shares in the last quarter. Evergreen Capital Management LLC lifted its holdings in Intuitive Surgical by 0.5% during the 1st quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock worth $2,124,000 after buying an additional 20 shares during the last quarter. Finally, Rise Advisors LLC grew its position in shares of Intuitive Surgical by 5.6% in the 1st quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock worth $187,000 after acquiring an additional 20 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on ISRG shares. Hsbc Global Res raised Intuitive Surgical to a “strong-buy” rating in a research report on Thursday, October 23rd. Leerink Partners boosted their target price on shares of Intuitive Surgical from $593.00 to $600.00 and gave the company an “outperform” rating in a research note on Wednesday, October 22nd. Zacks Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a report on Friday, October 24th. Erste Group Bank reaffirmed a “hold” rating on shares of Intuitive Surgical in a report on Wednesday, July 23rd. Finally, Jefferies Financial Group boosted their price objective on shares of Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a research report on Wednesday, October 22nd. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus price target of $608.92.

Intuitive Surgical Stock Up 2.2%

Shares of NASDAQ:ISRG opened at $560.00 on Monday. The company’s 50-day moving average price is $471.89 and its 200 day moving average price is $501.11. The company has a market cap of $200.75 billion, a PE ratio of 74.07, a P/E/G ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, topping the consensus estimate of $1.99 by $0.41. The firm had revenue of $2.51 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. Intuitive Surgical’s quarterly revenue was up 22.9% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.84 EPS. As a group, equities analysts anticipate that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.

Insider Transactions at Intuitive Surgical

In other news, insider Gary S. Guthart sold 2,800 shares of the stock in a transaction on Friday, October 24th. The stock was sold at an average price of $546.27, for a total value of $1,529,556.00. Following the completion of the transaction, the insider owned 17,120 shares of the company’s stock, valued at approximately $9,352,142.40. This represents a 14.06% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, VP Fredrik Widman sold 2,067 shares of Intuitive Surgical stock in a transaction dated Wednesday, November 5th. The shares were sold at an average price of $550.00, for a total transaction of $1,136,850.00. Following the sale, the vice president owned 473 shares in the company, valued at approximately $260,150. This represents a 81.38% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold 98,078 shares of company stock worth $51,445,892 over the last quarter. Insiders own 0.70% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.